News

Researcher Spotlight: David Scott, MBCHB, PhD

The disease course for follicular lymphoma (FL) is highly variable, and while many patients respond to treatment, some may experience relapse or evolution of disease into a more aggressive form of lymphoma. By studying genetic mutations, gene and protein expression, and interactions between lymphoma cells and their environment, Dr. Scott’s LRF research aims to develop tools that can reliably predict patient outcomes and guide treatment decision-making.

It’s their fifth cycle of funding for researchers at the BC Cancer Centre for Lymphoid Cancer who are part of the renewal of a coveted Terry Fox New Frontiers Program Projects Grant, following the 2022 competition. 

Five Canadian cancer research teams will share $22.4 million to expand their research into key areas of cancer treatment after winning the 2022 Terry Fox New Frontiers Program Project Grant (PPG) competition. Notably, three of the program project leaders are women and funding from two partner organizations is supporting two projects.

Read the full press release here.